Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Ongoing efforts against Huntington’s disease
December 2018
SHARING OPTIONS:

POMEZIA, Italy—IRBM and the CHDI Foundation have extended their collaboration focused on pursuing new therapeutic approaches to addressing Huntington’s disease. The two partners have worked together since 2011, looking into mechanistic and translational research in addition to tailored drug discovery solutions on IRBM's part. The extension includes continued access to IRBM's compound collection and peptide libraries. No additional financial details were disclosed.
 
“We are proud to be involved with this world-leading initiative to improve the quality of life of patients fighting against this terrible disease. Together with CHDI we are fully committed to help them; they deserve nothing less than our daily dedication,” Piero Di Lorenzo, president and founder of IRBM, said in a press release.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.